F
F. Driss
Researcher at French Institute of Health and Medical Research
Publications - 27
Citations - 1531
F. Driss is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Hepatitis B virus & Hepatitis. The author has an hindex of 17, co-authored 27 publications receiving 1501 citations.
Papers
More filters
Journal ArticleDOI
Transmission of hepatitis B from hepatitis-B-seronegative subjects.
Valérie Thiers,D. Kremsdorf,Huub Schellekens,A. Goudeau,John J. Sninsky,E. Nakajima,D Mack,F. Driss,Jack R. Wands,Pierre Tiollais,C. Brechot +10 more
TL;DR: PCR with HBV primers may unambigously identify HBV infectious particles among non-A, non-B viruses and is a potentially useful diagnostic test for detection of HBV DNA sequences in serum.
Journal ArticleDOI
Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area.
Patrizia Paterlini,Patrizia Paterlini,F. Driss,Bertrand Nalpas,Emilio Pisi,Emilio Pisi,Dominique Franco,Pierre Berthelot,Christian Bréchot,Christian Bréchot +9 more
TL;DR: Sequence analysis of a hypervariable region in the E2/NS1 gene of HCV showed significant variations between the viral molecules isolated from the nontumorous, tumorous and serum samples and assessed that liver tumor cells did contain HCV RNA genomes.
Journal ArticleDOI
Efficacy and limitations of a specific immunotherapy in chronic hepatitis B.
Stanislas Pol,Bertrand Nalpas,F. Driss,Marie-Louise Michel,Pierre Tiollais,Jacques Denis,Christian Bréchot +6 more
TL;DR: This controlled study offers direct evidence that the HBV vaccine may decrease HBV replication in chronic hepatitis B patients and emphasizes the need for reinforced immunization strategies as well as combination therapies.
Journal ArticleDOI
Specific Vaccine Therapy in Chronic Hepatitis B: Induction of T Cell Proliferative Responses Specific for Envelope Antigens
Isabelle Couillin,Stanislas Pol,Stanislas Pol,M. Mancini,F. Driss,Christian Bréchot,Christian Bréchot,Pierre Tiollais,Marie-Louise Michel +8 more
TL;DR: Reduction of serum HBV DNA in some of persons with chronic active HBV replication suggests that induction of CD4+ T cell responses could be important in controlling viremia during vaccine therapy of chronic HBV carriers.